111 related articles for article (PubMed ID: 15049326)
1. No evidence for reduced 25-hydroxyvitamin D serum level in melanoma patients.
Reichrath J; Querings K
Cancer Causes Control; 2004 Feb; 15(1):97-8. PubMed ID: 15049326
[No Abstract] [Full Text] [Related]
2. Circulating vitamin D-binding protein and free 25-hydroxyvitamin D concentrations in patients with melanoma: A case-control study.
Navarrete-Dechent C; Del Puerto C; Molgó M; González S; Pérez-Mateluna G; Uribe P; Camargo CA; Borzutzky A
J Am Acad Dermatol; 2017 Sep; 77(3):575-577. PubMed ID: 28807113
[No Abstract] [Full Text] [Related]
3. Association of 25-hydroxyvitamin D levels and cutaneous melanoma: A nested case-control study of the Women's Health Initiative Observation Study.
Kwon GP; Gamba CS; Stefanick ML; Swetter SM; Li S; Shi RZ; Clarke CA; Feldman D; Millen AE; Messina C; Shikany JM; Manson JE; Chlebowski RT; Tang JY
J Am Acad Dermatol; 2018 Jul; 79(1):145-147. PubMed ID: 29908819
[No Abstract] [Full Text] [Related]
4. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients.
Nürnberg B; Gräber S; Gärtner B; Geisel J; Pföhler C; Schadendorf D; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3669-74. PubMed ID: 19667163
[TBL] [Abstract][Full Text] [Related]
5. Melanoma risk is associated with vitamin D receptor gene polymorphisms.
Zeljic K; Kandolf-Sekulovic L; Supic G; Pejovic J; Novakovic M; Mijuskovic Z; Magic Z
Melanoma Res; 2014 Jun; 24(3):273-9. PubMed ID: 24638155
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in treated melanoma patients on follow up.
MacKie RM
Br J Dermatol; 2010 Mar; 162(3):697. PubMed ID: 20030636
[No Abstract] [Full Text] [Related]
7. 25-Hydroxyvitamin D in Patients With Melanoma and Factors Associated With Inadequate Levels.
Hernández-Ostiz S; Pérez-Ramada MD; Ortiz B; Requena C; Ribas G; Aznar E; Nagore E
Actas Dermosifiliogr; 2016 Nov; 107(9):758-764. PubMed ID: 27418183
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic serum 25-hydroxyvitamin D and melanoma risk.
Stenehjem JS; Støer NC; Ghiasvand R; Grimsrud TK; Babigumira R; Rees JR; Nilsen LT; Johnsen B; Thorsby PM; Veierød MB; Robsahm TE
Sci Rep; 2020 Nov; 10(1):20129. PubMed ID: 33208828
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and melanoma: state of the art and possible therapeutic uses.
Paolino G; Moliterni E; Corsetti P; Didona D; Bottoni U; Calvieri S; Mattozzi C
G Ital Dermatol Venereol; 2019 Feb; 154(1):64-71. PubMed ID: 29249122
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status and risk for malignant cutaneous melanoma: recent advances.
Ombra MN; Paliogiannis P; Doneddu V; Sini MC; Colombino M; Rozzo C; Stanganelli I; Tanda F; Cossu A; Palmieri G
Eur J Cancer Prev; 2017 Nov; 26(6):532-541. PubMed ID: 28125434
[TBL] [Abstract][Full Text] [Related]
11. Monitoring vitamin D in the patient with melanoma: impact of sun avoidance on vitamin D levels of patients with melanoma at a U.K. tertiary-referral melanoma service.
Lo MCI; Maraka J; Garioch J; John WG; Moncrieff M
Br J Dermatol; 2017 Jul; 177(1):282-283. PubMed ID: 27639181
[No Abstract] [Full Text] [Related]
12. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
Moreno-Arrones OM; Zegeer J; Gerbo M; Manrique-Silva E; Requena C; Traves V; Nagore E
Melanoma Res; 2019 Dec; 29(6):664-667. PubMed ID: 31469708
[TBL] [Abstract][Full Text] [Related]
13. Mycosis Fungoides and Vitamin D Status: Analyses of Serum 25-Hydroxyvitamin D Levels and Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene.
Incel Uysal P; Alli N; Hayran Y; Candar T
Acta Dermatovenerol Croat; 2018 Apr; 26(1):8-14. PubMed ID: 29782293
[TBL] [Abstract][Full Text] [Related]
14. Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study.
Afzal S; Nordestgaard BG; Bojesen SE
J Invest Dermatol; 2013 Mar; 133(3):629-636. PubMed ID: 23190899
[TBL] [Abstract][Full Text] [Related]
15. In praise of small studies.
Diffey BL
Br J Dermatol; 2011 Jul; 165(1):3-4. PubMed ID: 21707572
[No Abstract] [Full Text] [Related]
16. Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma.
Gambichler T; Bindsteiner M; Höxtermann S; Kreuter A
Br J Dermatol; 2013 Mar; 168(3):625-8. PubMed ID: 22880705
[TBL] [Abstract][Full Text] [Related]
17. Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.
Moliterni E; Paolino G; Veronese N; Bottoni U; Corsetti P; Cardone M; Didona D; Lopez T; Calvieri S
G Ital Dermatol Venereol; 2018 Oct; 153(5):732-733. PubMed ID: 30246955
[No Abstract] [Full Text] [Related]
18. Sun exposure before and after a diagnosis of cutaneous malignant melanoma: estimated by developments in serum vitamin D, skin pigmentation and interviews.
Idorn LW; Philipsen PA; Wulf HC
Br J Dermatol; 2011 Jul; 165(1):164-70. PubMed ID: 21457211
[TBL] [Abstract][Full Text] [Related]
19. 25-Hydroxyvitamin D serum levels and melanoma risk: a case-control study and evidence synthesis of clinical epidemiological studies.
Cattaruzza MS; Pisani D; Fidanza L; Gandini S; Marmo G; Narcisi A; Bartolazzi A; Carlesimo M
Eur J Cancer Prev; 2019 May; 28(3):203-211. PubMed ID: 29438161
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and melanoma incidence and mortality.
Berwick M; Erdei EO
Pigment Cell Melanoma Res; 2013 Jan; 26(1):9-15. PubMed ID: 22947439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
